# Medtronic Cardiac Ablation Solutions trials: 37 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials with Medtronic Cardiac Ablation Solutions as lead sponsor, 9 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Medtronic Cardiac Ablation Solutions: 37 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/medtronic-cardiac-ablation-solutions

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 9
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 27, 2026 | NCT07789925 | Sphere-9 PAF China Study | Medtronic Cardiac Ablation Solutions | Not applicable | Not yet recruiting | Paroxysmal Atrial Fibrillation (PAF) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789925) |
| May 14, 2026 | NCT07585968 | Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT) | Medtronic Cardiac Ablation Solutions | Not applicable | Recruiting | Ventricular Tachycardia | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585968) |
| May 8, 2026 | NCT07575828 | Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Not yet recruiting | Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575828) |
| December 30, 2025 | NCT07308847 | Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation... | Medtronic Cardiac Ablation Solutions | Not applicable | Active not recruiting | Paroxysmal AF | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308847) |
| December 23, 2025 | NCT07298473 | Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and... | Medtronic Cardiac Ablation Solutions | Not applicable | Recruiting | Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298473) |
| March 5, 2025 | NCT06858306 | SPHERE Per-AF Post-Approval Study | Medtronic Cardiac Ablation Solutions | Observational | Active not recruiting | Persistent Atrial Fibrillation | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06858306) |
| November 25, 2024 | NCT06703489 | Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia... | Medtronic Cardiac Ablation Solutions | Not applicable | Recruiting | Ventricular Tachycardia (VT) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06703489) |
| August 29, 2024 | NCT06578104 | PULSED AF Post-Approval Study | Medtronic Cardiac Ablation Solutions | Observational | Recruiting | Atrial Fibrillation | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06578104) |
| May 1, 2024 | NCT06393920 | PulseSelect™ PFA Global Registry | Medtronic Cardiac Ablation Solutions | Observational | Recruiting | Atrial Fibrillation | 1,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06393920) |
| September 7, 2023 | NCT06026345 | Affera Global Registry | Medtronic Cardiac Ablation Solutions | Observational | Active not recruiting | Atrial Fibrillation | 540 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06026345) |
| February 9, 2022 | NCT05230524 | DIAMOND AF Post-Approval Study | Medtronic Cardiac Ablation Solutions | Observational | Terminated | Paroxysmal Atrial Fibrillation | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05230524) |
| February 7, 2022 | NCT05227053 | STOP AF First Post-Approval Study | Medtronic Cardiac Ablation Solutions | Observational | Completed | Paroxysmal Atrial Fibrillation | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05227053) |
| December 3, 2021 | NCT05144503 | Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Recruiting | Atrial Fibrillation | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05144503) |
| November 15, 2021 | NCT05120193 | Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05120193) |
| November 10, 2021 | NCT05115214 | Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Recruiting | Atrial Fibrillation | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05115214) |
| August 16, 2021 | NCT05005949 | STOP Persistent AF PAS | Medtronic Cardiac Ablation Solutions | Observational | Active not recruiting | Persistent Atrial Fibrillation | 393 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05005949) |
| February 2, 2021 | NCT04735016 | DiamondTemp Global Registry | Medtronic Cardiac Ablation Solutions | Observational | Active not recruiting | Arrhythmia | 545 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04735016) |
| December 26, 2019 | NCT04211441 | Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation, Atrial Flutter, Ventricular Tachycardia | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04211441) |
| December 26, 2019 | NCT04210622 | An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation, Atrial Flutter | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04210622) |
| December 13, 2019 | NCT04198701 | Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation | 421 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04198701) |
| August 22, 2018 | NCT03643224 | DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Persistent Atrial Fibrillation, Atrial Fibrillation | 376 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03643224) |
| July 27, 2018 | NCT03604263 | ArcticLine Feasibility Study | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation, Atrial Flutter | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03604263) |
| November 7, 2017 | NCT03334630 | DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Paroxysmal Atrial Fibrillation, Atrial Fibrillation | 482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03334630) |
| October 19, 2017 | NCT03314753 | FIRE AND ICE Re-Ablations (Retrospective Data Collection) | Medtronic Cardiac Ablation Solutions | Observational | Completed | Atrial Fibrillation, Paroxysmal Atrial Fibrillation | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03314753) |
| April 18, 2017 | NCT03118518 | STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation | Medtronic Cardiac Ablation Solutions | Not applicable | Completed | Atrial Fibrillation, Atrial Fibrillation New Onset | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03118518) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 23 |
| Observational | 12 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 21 |
| Recruiting | 7 |
| Active not recruiting | 5 |
| Not yet recruiting | 2 |
| Terminated | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Atrial Fibrillation | 32 |
| Arrhythmias, Cardiac | 4 |
| Atrial Flutter | 3 |
| Tachycardia, Ventricular | 3 |
| Heart Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Pathologic Processes | 2 |
| Myocardial Ischemia | 2 |
| Tachycardia, Atrioventricular Nodal Reentry | 1 |
| Tachycardia, Supraventricular | 1 |
| Tachycardia | 1 |
| Bradycardia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Packing supply stores in the United States](https://specstream.ai/data/businesses/packing-supply-stores/united-states)
- [Pakistani restaurants in the United States](https://specstream.ai/data/businesses/pakistani-restaurants/united-states)
- [Paper mills in the United States](https://specstream.ai/data/businesses/paper-mills/united-states)
- [Patent law firms in the United States](https://specstream.ai/data/businesses/patent-law-firms/united-states)
- [Patio cover companies in the United States](https://specstream.ai/data/businesses/patio-cover-companies/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
